Digital Pharma: Byte-sized roundup
pharmafile | June 18, 2010 | News story | Medical Communications, Research and Development | FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media
This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media guidance may arrive this year and Genzyme’s French post-surgery educational website.
The NHS aims to tap into World Cup enthusiasm with an online game that allows football fans to test their fitness and help their chosen team to the top of a fitness league.
Players of the World Cup Football Fan Fitness Challenge pick an international and domestic team to represent and complete a simple health and lifestyle questionnaire (how much fruit and veg do you eat, do you use sunscreen, etc).
Based on their answers they are awarded a ‘transfer value’, which contributes to league tables of teams’ average fan value. Currently Australia tops the World Cup rankings and Aston Villa has a slim lead in the game’s Premiership. Built in association with the Men’s Health Forum and supported by the Football Association, the game is available on the NHS Choices website, Facebook and as an app for the iPhone.
– – – – –
Pfizer Oncology has launched a ‘virtual booth’, complete with virtual host, to its allow its educational and awareness raising efforts from the recent ASCO 2010 conference to live on in cyberspace.
The site has five main areas that focus on: its clinical development programme, patient enrollment in Pfizer cancer trials, the company’s cancer products, social responsibility and finally medical information for registered healthcare professionals from around the world.
– – – – –
Another company looking to gives its oncology efforts a new online push is Amgen, whose cancer site comes complete with a bookmarking function that allows users to store their favourite pages in a dock section within the site.
More easily navigable than the Pfizer site, Amgen Oncology covers much the same ground, but adds in sections detailing its patient advocacy, disease awareness and patient assistance efforts.
– – – – –
The first fruits from last’s FDA hearing on pharma use of the internet and social media could emerge before the end of this year. The ePharma Rx blog recently posted details of a short report indicating draft guidance from the US regulator will be forthcoming this year.
– – – – –
Genzyme has launched a French language website that aims to educate patients about a common complication of surgery and build “constructive dialogue” between patients and surgeons.
Post-operative adhesions are abnormal bands of scar tissue that interfere with the body’s natural movement that can cause a range of complications, including pelvic pain and bowel obstruction.
Genzyme’s Prevenir Les Adherences is the first news site to focus on adhesions and was created in collaboration with surgeons and patients, and with the support of the AFA (Association Francois Aupetit in inflammatory bowel disease) and AFVD (French Association for Overcoming Pain).
– – – – –
Dominic Tyer is web editor for Pharmafocus and InPharm.com and the author of the Digital Pharma blog He can be contacted via email, Twitter or LinkedIn.
Related Content
GSK’s Jemperli accepted for FDA review for endometrial cancer treatment
GSK has announced that the US Food and Drug Administration (FDA) has accepted its supplemental …
FDA approves ImmunityBio’s Anktiva bladder cancer treatment
ImmunityBio has announced that the US Food and Drug Administration (FDA) has approved Anktiva (N-803, …
EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment
Pfizer has announced that the European Commission (EC) has granted marketing authorisation for Emblaveo (aztreonam-avibactam) …
